DailyDoctor Archive Specialties Get app
Back to the 31 October 2026 edition

Practice changer · 05 of 05

Treat insomnia in sleep apnoea with CBT-I, not just sleep hygiene

For patients with both insomnia and OSA, offer CBT-I — including guided digital programmes — rather than sleep hygiene advice alone.

Design
Randomised trial with blinded outcome assessment
Population
88 adults with co-morbid insomnia and OSA, China
Primary outcome
Insomnia Severity Index and PSQI at 6 weeks and 3 months
Effect
ISI −9.5 vs −4.0 (d −1.18); PSQI −4.9 vs −1.8; AHI −6.0 vs +2.0 events/h

Co-morbid insomnia and obstructive sleep apnoea (COMISA) is common, and insomnia often undermines CPAP use. This Chinese trial randomised 88 patients with COMISA to six weekly sessions of clinician-guided digital CBT for insomnia — sleep restriction, stimulus control, cognitive restructuring and relapse prevention — or sleep hygiene education. Outcome assessors were blinded.

At three months, insomnia severity improved by 9.5 points with CBT-I against 4.0 with sleep hygiene, and sleep quality and daytime sleepiness also improved more. After treatment, the apnoea–hypopnoea index on attended polysomnography fell by 6 events per hour with CBT-I and rose by 2 with sleep hygiene. Sleepiness rose briefly during weeks 2–4, as expected with sleep restriction, without adverse events.

The concern that sleep restriction is unsafe in OSA has kept many patients from CBT-I. This small trial suggests a guided digital format is effective and tolerable. CPAP should continue where indicated.

  • Screen patients with OSA for insomnia, especially those struggling with CPAP.
  • Offer CBT-I, including guided digital formats, rather than sleep hygiene advice alone.
  • Warn patients that sleepiness may rise briefly during sleep restriction, and advise caution with driving in those weeks.
  • Continue CPAP or other OSA treatment alongside CBT-I.

Why it matters

It addresses the fear that CBT-I is unsafe in sleep apnoea, which has kept many patients from effective insomnia treatment.

Don't overread it

With 88 patients and three months' follow-up, the reduction in apnoea severity is a secondary finding that needs confirmation.

The statistics, in plain English

An effect size (d) of −1.18 on insomnia severity is large. The apnoea–hypopnoea index change was a secondary outcome measured only after treatment, so it is less certain.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

asthmasleepinterventioncopd

Tomorrow morning, before your first patient

One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app